Furthermore, we wanted to elucidate through which signaling pathway that miR‐378a‐3p and PDIA4 played a role in ovarian cancer, and corresponding findings suggested that miR‐378a‐3p stimulated ovarian cancer cell growth by downregulating PDIA4 and activating PI3K/AKT pathway. Here, PDIA4 is linked to ovarian carcinoma.